In-vitro Diagnostics Packaging Market Size, Share & Industry Analysis, By Material (Plastics, Glass, and Others), By Packaging Type (Bottles & Vials, Tubes, Boxes & Cartons, Trays & Blisters, Pouches & Bags, and Others), By End User (IVD Manufacturers, Clinical & Diagnostic Laboratories, Hospitals, Contract Packaging Organizations (CPOs), and Others), and Regional Forecast, 2026-2034

The global in-vitro diagnostics packaging market size was valued at USD 6.52 billion in 2025. The market is projected to grow from USD 6.94 billion in 2026 to USD 11.91 billion by 2034, exhibiting a CAGR of 6.98% during the forecast period.

In-vitro Diagnostics (IVD) packaging includes a broad range of solutions tailored for in-vitro diagnostic products, such as reagent bottles, specimen collection containers, vials, cartridges, blister packs, pouches, labels, and secondary packaging. The growing incidence of infectious diseases and chronic conditions, along with the rising use of molecular diagnostics and point-of-care testing, is fueling the demand for dependable IVD packaging that safeguards sensitive reagents and specimens while maintaining regulatory compliance and product integrity.

Many key industry players such as Amcor, Gerresheimer AG, and SCHOTT AG, operating in the market, are focusing on developing innovative packaging solutions and conducting R&D.

Download Free sample to learn more about this report.

IN-VITRO DIAGNOSTICS PACKAGING MARKET TRENDS

Growing Adoption of Sustainable and Smart IVD Packaging is a Major Trend Observed in the Market

The global market is being transformed by sustainability and digitalization. Manufacturers are progressively utilizing recyclable polymers, paper-based secondary packaging, lightweight designs, and mono-material formats to minimize environmental impact while adhering to strict regulatory standards. Concurrently, smart packaging technologies such as QR codes, RFID-enabled packaging tags, and serialized traceability labels are being incorporated to improve traceability, inventory management, anti-counterfeiting measures, and product authentication. These advancements facilitate laboratory automation and enhance supply chain visibility for temperature-sensitive diagnostic kits and reagents. As healthcare providers and regulators prioritize both environmental stewardship and product safety, sustainable and intelligent packaging solutions are emerging as a crucial competitive advantage for IVD packaging manufacturers globally.

MARKET DYNAMICS

MARKET DRIVERS

Download Free sample to learn more about this report.

Rising Demand for Molecular Diagnostics, Point-Of-Care Testing, and Infectious Disease Diagnostics is Driving Market Growth

The increasing need for molecular diagnostics, point-of-care testing (POCT), and diagnostics for infectious diseases is the primary factor propelling the global in-vitro diagnostics packaging market growth. The heightened use of PCR-based assays, immunoassays, rapid antigen tests, and genetic testing has significantly boosted the production of diagnostic kit packaging, reagents, cartridges, and specimen collection devices. These items necessitate specialized packaging that safeguards against contamination, moisture, oxygen, and physical harm while ensuring reagent stability and diagnostic precision during storage and transport. Furthermore, the growth of decentralized healthcare and home testing has led to a higher demand for compact, user-friendly, regulatory-compliant, and tamper-evident packaging, fostering ongoing innovation and sustained expansion within the IVD packaging sector.

MARKET RESTRAINTS

Stringent Regulatory Compliance Requirements and High Packaging Validation Costs Restrict Market Growth

The stringent requirements for regulatory compliance and the elevated costs associated with packaging validation are hindering the market. Packaging manufacturers must adhere to strict international regulations that encompass sterility, biocompatibility, labeling, traceability, container closure integrity, and product stability prior to the commercialization of packaging solutions. The need for extensive validation, compatibility testing, and thorough documentation extends development timelines and raises operational costs, especially for customized packaging utilized in advanced molecular diagnostics and high-value reagents. Moreover, the frequent revisions to global regulatory frameworks necessitate ongoing investments in quality systems and manufacturing processes. These costs associated with compliance create obstacles for smaller manufacturers, elevate overall packaging expenses, and may result in delays in product launches within highly regulated healthcare markets.

MARKET OPPORTUNITIES

Expansion of Point-of-Care and Home-Based Diagnostics Offers Potential Growth Opportunities

The swift growth of point-of-care (POC) and home-based diagnostic testing offers a substantial opportunity for expansion within the global IVD packaging market. The escalating need for decentralized healthcare, self-testing kits, and rapid diagnostic solutions necessitates packaging that is compact, user-friendly, tamper-evident, and capable of safeguarding sensitive reagents across various storage conditions. Manufacturers can create innovative packaging featuring improved barrier properties, simplified dispensing systems, and integrated instructions tailored for non-professional users. Additionally, the increasing investments in personalized medicine, digital healthcare, and infectious disease surveillance further amplify the demand for advanced packaging formats that enhance usability, ensure product integrity, and facilitate efficient distribution through retail pharmacies, hospitals, and e-commerce platforms.

MARKET CHALLENGES

Maintaining Product Stability across Complex Supply Chains Poses a Critical Challenge to Market Growth

Maintaining the stability and integrity of sensitive diagnostic reagents across global supply chains is a significant challenge for the IVD packaging market. Numerous molecular diagnostics, immunoassays, and specialty reagents necessitate protection from moisture, oxygen, light, contamination, and temperature variations during transport and storage. Packaging manufacturers are tasked with balancing rigorous performance standards with cost-effectiveness and sustainability objectives while adhering to changing international regulatory requirements. Frequent disruptions in logistics, longer transportation distances, and an increasing demand for cold-chain distribution further complicate the design of packaging. The development of reliable, high-performance packaging that ensures diagnostic accuracy without substantially raising overall product costs remains a crucial challenge within the industry.

Segmentation Analysis

By Material

Versatility, Cost Efficiency, and Superior Barrier Performance to Boost Plastics Segment Dominance

Based on material, the market is divided into plastics, glass, and others.

The plastics segment is expected to account for the largest market share over the forecast period due to its ideal blend of durability, chemical resistance, lightweight design, and cost efficiency. Additionally, plastics offer significant design flexibility, allowing for the creation of intricate molded components for automated diagnostic systems while ensuring dimensional precision. Their excellent moisture and contamination barrier properties contribute to the preservation of reagent stability and the extension of shelf life. Moreover, plastics facilitate high-volume, precise manufacturing at competitive prices, making them the material of choice for clinical laboratories, hospitals, diagnostic kit manufacturers, and point-of-care testing applications.

The glass segment is expected to grow at a CAGR of 6.83% over the forecast period. 

By Packaging Type

Extensive Reagent Storage Requirements and Superior Product Protection to Propel Bottles & Vials Segment Growth

Based on packaging type, the market is divided into bottles & vials, tubes, boxes & cartons, trays & blisters, pouches & bags, and others.

The bottles and vials segment is set to register the largest market share during the forecast period. Bottles and vials are the predominant packaging formats in the market, primarily utilized for the storage of liquid reagents, buffers, calibrators, controls, and biological samples essential for various diagnostic tests. These containers are available in a variety of sizes and materials, making them suitable for both manual laboratory processes and automated diagnostic analyzers. Their design allows for the inclusion of tamper-evident closures, dispensing systems, and secure sealing, which significantly improves safety and ensures compliance with regulatory standards. Furthermore, the extensive application of bottles and vials in clinical laboratories, hospitals, research institutions, and the manufacturing of diagnostic kits solidifies their status as the most favored and highest-volume packaging type within the market.

The tubes segment is expected to grow at a CAGR of 7.04% over the forecast period.

By End User

To know how our report can help streamline your business, Speak to Analyst

IVD Manufacturers to Take the Lead in Market Due to High Packaging Consumption and Integrated Production Requirements

Based on end user, the market is segmented into IVD Manufacturers, clinical & diagnostic laboratories, hospitals, contract packaging organizations (CPOs), and others.

IVD manufacturers are expected to hold a dominant in-vitro diagnostics packaging market share over the forecast period, as they are the main buyers and users of packaging components during the production of diagnostic kits, reagents, specimen collection tubes, and consumables. Packaging is an integral part of every phase of product manufacturing, encompassing sterile filling and sealing, labeling, and distribution, thus rendering it a vital component of the production process. Moreover, the ongoing launch of molecular diagnostics, immunoassays, and point of care testing products has led to a heightened demand for packaging directly from manufacturers. Their extensive procurement, customization requirements, and focus on product protection, traceability, and regulatory compliance position IVD manufacturers as the dominant end-user in the market.

The clinical & diagnostic laboratories segment is projected to grow at a CAGR of 6.63% over the forecast period. 

In-vitro Diagnostics Packaging Market Regional Outlook

By geography, the market is categorized into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America held the dominant share in 2024, valued at USD 2.19 billion, and maintained its leading position in 2025, with a value of USD 2.35 billion. North America is largely propelled by its sophisticated diagnostics ecosystem, substantial healthcare spending, and swift integration of molecular diagnostics and point-of-care testing. Significant investments from prominent IVD manufacturers, rigorous FDA quality regulations, and a growing need for automation-friendly, high-performance packaging solutions are consistently driving innovation and the demand for premium packaging throughout the region.

U.S. In-vitro Diagnostics Packaging Market

Based on North America’s strong contribution and the U.S. dominance within the region, the U.S. market was valued at around USD 1.91 billion in 2025, accounting for roughly 29.32% of global sales. A significant concentration of international IVD manufacturers and ongoing product innovation propels the U.S. market. The growing acceptance of home-based diagnostic kits, advantageous reimbursement policies for advanced diagnostics, and stringent regulatory standards for product safety, traceability, and labeling greatly enhance the demand for specialized IVD packaging production.

Europe

Europe is projected to grow at a CAGR of 6.16% in the coming years, the third-highest among all regions, and reached USD 1.00 billion in 2025. The market in Europe is propelled by strict regulatory requirements set forth by the IVDR, a rise in sustainability efforts, and robust diagnostic testing within public healthcare systems. The increasing focus on recyclable packaging materials, product traceability, and quality assurance motivates manufacturers to embrace innovative, eco-friendly packaging solutions, thereby facilitating the growth of molecular diagnostic applications in the region.

U.K. In-vitro Diagnostics Packaging Market

The U.K. market in 2025 was valued at USD 0.18 billion, representing approximately 2.71% of global revenues.

Germany In-vitro Diagnostics Packaging Market

Germany’s market was valued at approximately USD 0.25 billion in 2025, equivalent to around 3.84% of global sales.

Asia Pacific

Asia Pacific is estimated to reach USD 1.82 billion in 2025 and secure second place in the market. The expansion of healthcare infrastructure, an increase in diagnostic laboratory capabilities, and a swiftly rising demand for affordable diagnostic testing are driving market growth in the region. The surge in investments in local in-vitro diagnostic manufacturing, government healthcare initiatives, and the broadening of infectious disease screening programs are driving the need for cost-effective, scalable, and high-volume packaging solutions in emerging economies.

Japan In-vitro Diagnostics Packaging Market

The Japanese market in 2025 was valued at USD 0.32 billion, accounting for roughly 4.97% of global revenues. The market in Japan is propelled by technological advancements, an aging demographic, and the extensive use of high-precision diagnostic testing. There is a notable demand for premium packaging that offers enhanced high-barrier material properties, effective contamination control, and compatibility with automated laboratory systems.

China In-vitro Diagnostics Packaging Market

China’s market is projected to be one of the largest globally, with 2025 revenues valued at around USD 0.56 billion, representing roughly 8.65% of global sales.

India In-vitro Diagnostics Packaging Market

The Indian market in 2025 was valued at around USD 0.47 billion, accounting for roughly 7.20% of global revenues.

Latin America

The Latin America market was valued at USD 0.80 billion in 2025 and is expected to witness moderate growth during the forecast period. The market is bolstered by enhanced access to healthcare, a rise in investments in diagnostic laboratories, and the expansion of infectious disease surveillance initiatives. The demand for dependable, cost-effective, and regulatory-compliant packaging throughout the region is being driven by growing public health programs, an increase in private healthcare expenditures, and a gradual shift toward local production of diagnostic kits.

Middle East & Africa

In the Middle East & Africa, South Africa was valued at USD 0.16 billion in 2025. The market in the Middle East & Africa is propelled by the growth of healthcare infrastructure, heightened government funding for diagnostic services, and a surge in both infectious and chronic diseases. The expansion of hospital laboratories, national disease screening programs, and enhanced access to both imported and domestically produced diagnostic products are contributing to the increased demand for robust and temperature-stable IVD packaging solutions.

Saudi Arabia In-vitro Diagnostics Packaging Market

The Saudi Arabian market was valued at approximately USD 0.19 billion in 2025, accounting for roughly 2.95% of global revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Focus on Expanding Product Launches and Acquisitions by Key Players to Propel Market Progress

The global in-vitro diagnostics packaging market has a semi-consolidated structure, with prominent players including Amcor, Gerresheimer AG, and SCHOTT AG. The significant market share of these companies is attributed to numerous strategic initiatives, including collaborations among operating entities to advance research.

• For instance, in April 2026, Gerresheimer AG declared the enhancement of its production capacity for high-value tubular glass to meet the rising demand from manufacturers in the pharmaceutical and in-vitro diagnostic This investment is directed toward premium glass vials and cartridges that are utilized for sensitive diagnostic reagents and applications in molecular testing. The increased capacity bolsters Gerresheimer's capability to provide packaging that offers improved dimensional accuracy, chemical resistance, and contamination management, thereby responding to the growing global need for laboratory diagnostics, personalized medicine, and point-of-care testing.

Other notable players in the global market include TekniPlex Healthcare, Sanner GmbH, and Oliver Healthcare Packaging. These companies are expected to prioritize new product launches and collaborations to increase their global market share during the forecast period.

LIST OF KEY IN-VITRO DIAGNOSTICS PACKAGING COMPANIES PROFILED

• Amcor (Switzerland)
• Gerresheimer AG (Germany)
• SCHOTT AG (Germany)
• TekniPlex Healthcare (U.S.)
• Sanner GmbH (Germany)
• Oliver Healthcare Packaging (U.S.)
• SGD Pharma (France)
• Corning Incorporated (U.S.)
• Stevanato Group (Italy)
• Comar LLC (U.S.)
• West Pharmaceutical Services (U.S.)
• Nelipak Healthcare Packaging (U.S.)
• AptarGroup, Inc. (U.S.)
• DWK Life Sciences (Germany)
• Nipro Corporation (Japan)

KEY INDUSTRY DEVELOPMENTS

• February 2026: Stevanato Group broadened the commercialization of its EZ-fill® ready-to-use sterile containment platform, which is intended for pharmaceutical and diagnostic uses. This platform features pre-sterilized vials and containers that aim to enhance filling efficiency while reducing the risks of contamination prevention. Initially created for injectable products, this technology has seen increased utilization in the packaging of high-value diagnostic reagents, where sterility, compatibility with automation, and adherence to regulatory standards are becoming ever more critical for contemporary IVD manufacturing facilities.
• September 2025: SCHOTT AG increased its production capacity for FIOLAX borosilicate glass tubing to meet the rising global demand for primary packaging in pharmaceuticals and diagnostics. This investment improves the reliability of supply for glass vials utilized in diagnostic reagents, laboratory chemicals, and molecular diagnostic kits. Enhanced production capabilities also cater to manufacturers who need high chemical durability, minimal extractables, and excellent dimensional consistency for sensitive laboratory and diagnostic applications.
• May 2025: West Pharmaceutical Services launched advanced elastomer closure technologies tailored for highly sensitive pharmaceutical and diagnostic applications. These innovative containment solutions enhance container closure integrity, minimize contamination risks, and promote long-term stability of reagents. This development is advantageous for manufacturers involved in molecular diagnostics, immunoassays, and specialty laboratory reagents that necessitate rigorous packaging performance in challenging storage and transportation environments.
• October 2024: AptarGroup broadened its Active Material Science portfolio by advancing innovations in moisture-management and active packaging technologies. These solutions are designed to safeguard moisture-sensitive diagnostic reagents and biological materials throughout storage and transportation. This development enhances Aptar's standing in healthcare packaging and addresses the growing global need for reliable packaging systems utilized in molecular diagnostics, laboratory consumables, and point-of-care testing products.
• June 2024: Oliver Healthcare Packaging broadened its manufacturing presence in Europe by launching new production capabilities specifically for sterile medical and diagnostic packaging. This facility enhances the output of high-barrier pouches, lids, and thermoformed packaging utilized for diagnostic devices and laboratory consumables. The expansion bolsters the resilience of the regional supply chain while addressing the growing European demand for sterile packaging solutions that meet MDR and IVDR quality standards.

REPORT COVERAGE

The in-vitro diagnostics packaging market analysis includes a comprehensive study of market size & forecast across all market segments included in the report. It includes details on the market dynamics and market trends expected to drive the market over the forecast period. It provides information on key aspects, including technological advancements, pipeline candidates, the regulatory environment, regional insights, and product launches. Additionally, it details partnerships, mergers & acquisitions, and key industry developments, and their prevalence by key regions. The global market research report also provides a detailed competitive landscape, including market share and profiles of key operating players.

Request for Customization   to gain extensive market insights.

Report Scope and Segmentation